News
We are extremely pleased to have taken 2nd place in the Health & Nutrition Vertical of this years' Venture competition!
We are delighted that our efforts have been recognized by being awarded the RNA Therapeutics Innovator of the Year - Switzerland in the Global Health & Pharma Excellence Awards 2024!
A featured article in the quarterly installment of HGP magazine can be found here.
Procavea is very proud to be recognised as an official ETH Zurich Spin-off company!
We made it through of the Venture Kick Stage 3!
Huge thanks to Venture Kick for ending 2023 on a high note! We are really pleased for the continued support, and to the expert Jury for helping us challenge our business case and seeing the potential of our unique protein-based molecular delivery technology to solve a major limitation in the application of RNA Therapeutics.
This is a huge boost for us at a critical time in our growth, looking forward to a productive and impactful 2024!! The official press release can be found on the Venture Kick website.
Procavea supported by Gebert Ruf Stiftung through InnoBooster start-up financing!
We are extremely grateful to the Gebert Rüf Stiftung for seeing the potential of our team & technology and providing this very important boost for our pre-clinical development efforts. Congratulations to all of the other winners, too!
«InnoBooster» aims at speeding up innovative, science-based deep tech businesses which have already entered the Venture Kick process and promise high market potential. Up to CHF 150,000 for a maximum of 1.5 years can be granted to top talents with a clear plan and funding need for accelerated market entry. The key selection criteria are Originality, Effectiveness, Transfer potential and Interdisciplinarity.
Procavea receives Ones to Watch for Innovative Protein-Based Delivery Platforms accolade in the Global Health & Pharma Excellence Awards 2023!
Read about it in the Q3 edition of Global Health & Pharma magazine.
We are honored to have passed Stage 2 of the Venture Kick program!
We are really grateful to the Venture Kick team and expert jury for seeing the potential in our technology platform and business plans. In this second business case stage, we have been awarded 40,000 CHF, which will go towards business development. In addition to this financial backing, the entrepreneurial support and access to the Venture Kick network is a big boost for Procavea. The official press release can be found on the Venture Kick website.
The philanthropic initiative Venture Kick provides up to CHF 150,000 in seed funding to Swiss startups. In addition, it offers a well- structured entrepreneurial path towards building a winning business. Startups pitch to expert juries at three stages to obtain funding, gaining direct feedback and access to an international network of successful entrepreneurs and investors.
Very excited to have made it into the first stage of Venture Kick!
Thank you to the VK team and expert Jury for their belief in our platform.
Beyond therapeutic delivery, nonviral protein cages are also promising platforms for medical imaging, as shown in our most recent collaborative publication with researchers at Northwestern University- read about it here !
Pleased to share a collaborative publication with ETH Zurich researchers on enzymatic protein cage modification- it's open access and can be found here
We made it into the Innosuisse Core Coaching programme for start-ups
With the help of our excellent Innosuisse coach, we've completed the initial coaching and now entered the Core Coaching phase, where the focus is on creating and developing business traction. Looking forward to making the most of the Innosuisse network!
Accepted into the initial programme of Innosuisse Start-up Coaching
We are very pleased to have been accepted into this support programme, where the focus is on challenging and optimising our business model.
We won the Swiss Technology Award!
A unique experience: At the Swiss Innovation Forum on 18 November in Basel, we pitched for the Swiss Technology Award 2021 in the category ‘Inventors’. We are proud that we could convince the top-class jury and receive the coveted award in front of numerous decision-makers from business, politics and science. The trophy not only recognises our work – it also brings with it a high media radiance and significantly helps us to carry our project further into the future.
The Swiss Technology Award is the most important award for innovation and technology transfer in Switzerland. Every year, the prize is awarded to the most outstanding technology-based innovations and developments in the categories ‘Inventors’, ‘Start-ups (Rising Stars)’ and ‘Innovation Leaders’. It was awarded for the 33rd time this year.
Congratulations to Embotech and Belimo Automation, who won in the categories ‘Start-ups (Rising Stars)’ and ‘Innovation Leaders’.
Procavea selected as finalist for the Swiss Technology Award, 2021 !
We made it to the final of Switzerlands leading technology prize!
Around sixty start-ups, established companies as well as educational and research institutions applied for the Swiss Technology Award 2021, nine have reached the final. We are extremely proud to be among them. We will be pitching for first place in the category ‘Inventors’ at the Swiss Innovation Forum 2021 on 18 November in Basel. We are looking forward to this unique experience and the exchange with other innovative minds during the conference day. Further information can be found here.
The Swiss Technology Award is the most important award for innovation and technology transfer in Switzerland. Every year, the prize is awarded to the most outstanding technology-based innovations and developments in the categories ‘Inventors’, ‘Start-ups (Rising Stars)’ and ‘Innovation Leaders’. This year it will be awarded for the 33rd time.
Procavea's OP Platform selected as top 5 finalist for the ETH Spark Award
Interview with Tom Edwardson about himself and Procavea's RNA delivery technology - Read the article here
Our publication in CHIMIA gives an overview of the OP molecular delivery platform - It's open access!
Our Technology
We develop innovative molecular delivery solutions to enable both RNA and small molecule medicines and address unmet clinical needs.
Where to find us
Procavea Biotech AG
c/o ETH Zürich
HCI D 151.1/2
Vladimir-Prelog-Weg 1-5/10
8093 Zürich
Switzerland
Get in touch
Telephone: (+41) 044 632 29 74
Email: team@procavea.com
Copyright © 2024, Procavea Biotech
Logo by Natacha Ohannessian [design.at.nat@gmail.com]